Clopidogrel Versus Cilostazol in Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 870 participants.

Also called NCT06242132

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 870 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06242132
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06242132. Randomized; double masking; primary purpose treatment. Start 2022-06-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel Versus Cilostazol in Ischemic Stroke
Intervention (Drug)
Clopidogrel tablet
Intervention (Drug)
Cilostazol 100 MG
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06242132
Content hash
c0d213abbc2cf5eeaa51ed627656b7cd463153a36edc19877bc221c10ce06dd9